Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/173.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell (e.g., honey, etc.) > Hematopoietic cell
Description: Subject matter wherein the cell is a hematopoietic cell.

Patents under this class:
1 2 3 4 5 6 7 8

Patent Number Title Of Patent Date Issued
8679500 Compositions containing antibodies for treating CD5+ HLA-DR+ B or T cell related diseases Mar. 25, 2014
8663641 Anti-PSGL-1 antibodies Mar. 4, 2014
8647625 Anti-CD154 antibodies Feb. 11, 2014
8647617 Methods for modulating inflammatory and/or immune responses Feb. 11, 2014
8647624 Treatment of immune disorders with anti-CD70 antibody Feb. 11, 2014
8642041 Adenylyl cyclase-associated protein (CAP1) and uses thereof as a target for immuno-modulation Feb. 4, 2014
8637032 Antagonist anti-CD40 monoclonal antibodies and methods for their use Jan. 28, 2014
8623830 Compositions containing .alpha.-1-antitrypsin and methods for use Jan. 7, 2014
8617554 Anti-human CD52 immunoglobulins Dec. 31, 2013
8613926 Anti-C5a receptor antibodies Dec. 24, 2013
8597636 Method for treating autoimmune diseases and compositions therefor Dec. 3, 2013
8591900 Anti-CD40 antibodies Nov. 26, 2013
8580266 Immune modulation via C-type lectin Nov. 12, 2013
8580255 Method for the treatment of rheumatoid arthritis using a TLR2 antagonistic antibody Nov. 12, 2013
8568725 Method of treating transplant rejection with an anti-CD40 antibody Oct. 29, 2013
8562997 Methods of treating acute myeloid leukemia by blocking CD47 Oct. 22, 2013
8551485 Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cells Oct. 8, 2013
8545843 Treatment of vasculitis Oct. 1, 2013
8529902 Human monoclonal antibodies against CD20 Sep. 10, 2013
8524236 Methods of antagonizing the binding of CD40 to CD40L with CD40L-specific monovalent polypeptides in autoimmune individuals Sep. 3, 2013
8518403 Expression-enhanced polypeptides Aug. 27, 2013
8513028 Use of MLN51 gene and protein Aug. 20, 2013
8506949 Methods for modulating inflammatory and/or immune responses Aug. 13, 2013
RE44389 Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies Jul. 23, 2013
8475793 Engineered anti-TSLPR antibodies Jul. 2, 2013
8470318 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods Jun. 25, 2013
8465741 Antibodies and methods for making and using them Jun. 18, 2013
8420086 Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases Apr. 16, 2013
8409572 Monoclonal antibodies with enhanced ADCC function Apr. 2, 2013
8398979 Polypeptides, antibody variable domains and antagonists Mar. 19, 2013
8388971 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses Mar. 5, 2013
8377440 Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases Feb. 19, 2013
8361472 Anti-PSGL-1 antibodies Jan. 29, 2013
8361471 Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody Jan. 29, 2013
8361468 Humanized anti-C5aR antibodies Jan. 29, 2013
8337844 CD20-binding polypeptide compositions for treating autoimmune disease Dec. 25, 2012
8337851 Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancer Dec. 25, 2012
8337855 Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same Dec. 25, 2012
8333970 Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune disease Dec. 18, 2012
8333969 Use of immunesuppressant receptor Dec. 18, 2012
8329172 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody Dec. 11, 2012
8329181 Methods for treating B-cell lymphoma by administering an anti-CD20 antibody Dec. 11, 2012
8323653 Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease Dec. 4, 2012
8309091 CEACAM8-related method for treating autoimmune diseases Nov. 13, 2012
8303955 Humanized anti-CD40 antibodies and their methods of use Nov. 6, 2012
8298540 Methods of modulating T cell-mediated immune responses with anti-P-selectin glycoprotein ligand 1 antibodies Oct. 30, 2012
8287871 Methods of inducing cell death of an activated T cell with anti-PSGL-1 antibodies Oct. 16, 2012
8277810 Antagonist anti-CD40 antibodies Oct. 2, 2012
8246959 Dendritic cell-associated lectin-like molecules, compositions and methods of use Aug. 21, 2012
8246958 Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies Aug. 21, 2012

1 2 3 4 5 6 7 8

  Recently Added Patents
Radio communication device and sequence length adjusting method
Television with a stand
Animation control apparatus, animation control method, and non-transitory computer readable recording medium
Imaging lens having five lens elements, and electronic apparatus having the same
Method for repairing or replacing damaged tissue
System and method for managing investment funds
Image forming apparatus
  Randomly Featured Patents
Method and apparatus for alignment of signals for use in DNA based-calling
Electrical surge protector unit for desk top products
Printing hammer driving system
Cryptographic key split combiner
Sterile coupling device for drug container
Method for acquiring content information, and software product, collaboration system and collaboration server for acquiring content information
Infeed arrangement
Multi-output composite piezoelectric transformer with expansion vibration mode
Reorder buffer configured to allocate storage for instruction results corresponding to predefined maximum number of concurrently receivable instructions independent of a number of instructions
Circulating mRNA as diagnostic markers